BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3476385)

  • 1. Incidence and treatment of fungal infections in neutropenic patients.
    von Paleske A; Müllerleile U; Gressler V; Garbrecht M; Hossfeld DK
    Haematol Blood Transfus; 1987; 30():545-6. PubMed ID: 3476385
    [No Abstract]   [Full Text] [Related]  

  • 2. Human Exserohilum and Bipolaris infections: report of Exserohilum nasal infection in a neutropenic patient with acute leukemia and review of the literature.
    Douer D; Goldschmied-Reouven A; Segev S; Ben-Bassat I
    J Med Vet Mycol; 1987 Aug; 25(4):235-41. PubMed ID: 3312557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal infection and fever of unknown origin in neutropenic patients.
    Bodey GP
    Am J Med; 1986 May; 80(5C):112-9. PubMed ID: 3717185
    [No Abstract]   [Full Text] [Related]  

  • 4. Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients.
    Fainstein V; Bodey GP; Elting L; Maksymiuk A; Keating M; McCredie KB
    Antimicrob Agents Chemother; 1987 Jan; 31(1):11-5. PubMed ID: 3566234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Itraconazole versus ketoconazole for the prophylaxis of fungal infection in neutropenic children: results of two consecutive nonrandomized studies.
    Ninane J; Sluysmans T; Vermylen C; De Beule K; Woestenborghs R; Cauwenbergh G; Cornu G
    Pediatr Hematol Oncol; 1989; 6(4):349-53. PubMed ID: 2561916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungal infections complicating acute leukemia.
    Bodey GP
    J Chronic Dis; 1966 Jun; 19(6):667-87. PubMed ID: 5229422
    [No Abstract]   [Full Text] [Related]  

  • 7. Ketoconazole for prevention of fungal infections in neutropenic leukemia patients.
    Capnist G; Chisesi T; Dini E; Vaglia A; Piacentini I
    Haematologica; 1987; 72(2):185. PubMed ID: 3114079
    [No Abstract]   [Full Text] [Related]  

  • 8. Fungemia due to Fusarium solani in an immunocompromised child.
    Chaulk CP; Smith RW; Feagler JR; Verdirame J; Commers JR
    Pediatr Infect Dis; 1986; 5(3):363-6. PubMed ID: 3523454
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
    van't Wout JW; Novakova I; Verhagen CA; Fibbe WE; de Pauw BE; van der Meer JW
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():11-3. PubMed ID: 1663200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies.
    Tricot G; Joosten E; Boogaerts MA; Vande Pitte J; Cauwenbergh G
    Rev Infect Dis; 1987; 9 Suppl 1():S94-9. PubMed ID: 3027853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disseminated fusarium infection in two neutropenic children].
    Petit A; Tabone MD; Moissenet D; Auvrignon A; Landman-Parker J; Boccon-Gibod L; Leverger G
    Arch Pediatr; 2005 Jul; 12(7):1116-9. PubMed ID: 15964527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida krusei infectious arthritis. A rare complication of neutropenia.
    Nguyen VQ; Penn RL
    Am J Med; 1987 Nov; 83(5):963-5. PubMed ID: 3479022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative trial of ketoconazole and nystatin for prevention of fungal infection in neutropenic patients treated in a protective environment.
    Shepp DH; Klosterman A; Siegel MS; Meyers JD
    J Infect Dis; 1985 Dec; 152(6):1257-63. PubMed ID: 3905986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks and outcome of fungal infection in neutropenic children with hematologic diseases.
    Aytaç S; Yildirim I; Ceyhan M; Cetin M; Tuncer M; Kara A; Cengiz AB; Seçmeer G; Yetgin S
    Turk J Pediatr; 2010; 52(2):121-5. PubMed ID: 20560245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study.
    Walsh TJ; Rubin M; Hathorn J; Gress J; Thaler M; Skelton J; McKnight J; Browne M; Marshall D; Cotton D
    Arch Intern Med; 1991 Apr; 151(4):765-70. PubMed ID: 2012462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of systemic fungal infections in patients with hematological malignancies, neutropenia, and prolonged fever by early amphotericin B therapy.
    Zimmermann-Hösli MB; Stahel RA; Vogt P; Oelz O
    Klin Wochenschr; 1988 Oct; 66(20):1010-4. PubMed ID: 3236752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Itraconazole in neutropenic patients.
    van't Wout JW
    Chemotherapy; 1992; 38 Suppl 1():23-6. PubMed ID: 1319311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant amphotericin B therapy, granulocyte transfusions, and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient.
    Spielberger RT; Falleroni MJ; Coene AJ; Larson RA
    Clin Infect Dis; 1993 Apr; 16(4):528-30. PubMed ID: 8513060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B.
    Menichetti F; Del Favero A; Martino P; Bucaneve G; Micozzi A; D'Antonio D; Ricci P; Carotenuto M; Liso V; Nosari AM; Barbui T; Fasola G; Mandelli F;
    Ann Intern Med; 1994 Jun; 120(11):913-8. PubMed ID: 8172437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical liposomal amphotericin-B therapy in a neutropenic patient: breakthrough of disseminated Blastoschizomyces capitatus infection.
    Plum G; Scheid C; Franzen C; Schütt-Gerowitt H; Seifert H; Wickramanayake PD
    Zentralbl Bakteriol; 1996 Jul; 284(2-3):361-6. PubMed ID: 8837396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.